Notably regarded as a tumor suppressor in many cancers, SPRY4 is downregulated in glioblastoma, endometrial adenocarcinoma, perihilar cholangiocarcinoma (PHCC), breast carcinoma, melanoma, and also prostate, ovarian, and lung cancers [4–11]. This evidence concerns the gene SPRY4 and melanoma.